Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 4
1970 1
1988 1
1993 2
1995 1
1997 2
1999 2
2000 2
2003 1
2004 1
2008 3
2010 3
2011 3
2012 1
2013 4
2014 2
2015 5
2016 3
2017 8
2018 8
2019 5
2020 8
2021 12
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
SHOC2 Is a Critical Modulator of Sensitivity to EGFR-TKIs in Non-Small Cell Lung Cancer Cells.
Terai H, Hamamoto J, Emoto K, Masuda T, Manabe T, Kuronuma S, Kobayashi K, Masuzawa K, Ikemura S, Nakayama S, Kawada I, Suzuki Y, Takeuchi O, Suzuki Y, Ohtsuki S, Yasuda H, Soejima K, Fukunaga K. Terai H, et al. Among authors: kawada i. Mol Cancer Res. 2021 Feb;19(2):317-328. doi: 10.1158/1541-7786.MCR-20-0664. Epub 2020 Oct 26. Mol Cancer Res. 2021. PMID: 33106373
Functional dissection of the KRAS G12C mutation by comparison among multiple oncogenic driver mutations in a lung cancer cell line model.
Kobayashi K, Terai H, Yasuda H, Hamamoto J, Hayashi Y, Takeuchi O, Mitsuishi Y, Masuzawa K, Manabe T, Ikemura S, Kawada I, Suzuki Y, Soejima K, Fukunaga K. Kobayashi K, et al. Among authors: kawada i. Biochem Biophys Res Commun. 2021 Jan 1;534:1-7. doi: 10.1016/j.bbrc.2020.11.110. Epub 2020 Dec 8. Biochem Biophys Res Commun. 2021. PMID: 33302159 Free article.
Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study.
Ishii M, Terai H, Kabata H, Masaki K, Chubachi S, Tateno H, Nakamura M, Nishio K, Koh H, Watanabe R, Ueda S, Terashima T, Suzuki Y, Yagi K, Miyao N, Minematsu N, Inoue T, Nakachi I, Namkoong H, Okamori S, Ikemura S, Kamata H, Yasuda H, Kawada I, Hasegawa N, Fukunaga K; Keio COVID-19 Research Consortium (K-CORC) and the Keio Donner Project Team. Ishii M, et al. Among authors: kawada i. J Infect. 2020 Nov;81(5):e3-e5. doi: 10.1016/j.jinf.2020.08.052. Epub 2020 Sep 10. J Infect. 2020. PMID: 32920063 Free PMC article. No abstract available.
Thymoma-associated T-cell immunodeficiency after radiotherapy: A case report.
Nakagawara K, Chubachi S, Azekawa S, Otake S, Saito A, Okada M, Lee K, Masaki K, Koike N, Kamata H, Kawada I, Suzuki S, Ishii M, Fukunaga K. Nakagawara K, et al. Among authors: kawada i. Respir Med Case Rep. 2021 Apr 2;33:101408. doi: 10.1016/j.rmcr.2021.101408. eCollection 2021. Respir Med Case Rep. 2021. PMID: 34401256 Free PMC article.
IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer.
Manabe T, Yasuda H, Terai H, Kagiwada H, Hamamoto J, Ebisudani T, Kobayashi K, Masuzawa K, Ikemura S, Kawada I, Hayashi Y, Fukui K, Horimoto K, Fukunaga K, Soejima K. Manabe T, et al. Among authors: kawada i. Mol Cancer Res. 2020 Apr;18(4):549-559. doi: 10.1158/1541-7786.MCR-19-0956. Epub 2020 Jan 15. Mol Cancer Res. 2020. PMID: 31941753 Free article.
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer.
Ishioka K, Yasuda H, Hamamoto J, Terai H, Emoto K, Kim TJ, Hirose S, Kamatani T, Mimaki S, Arai D, Ohgino K, Tani T, Masuzawa K, Manabe T, Shinozaki T, Mitsuishi A, Ebisudani T, Fukushima T, Ozaki M, Ikemura S, Kawada I, Naoki K, Nakamura M, Ohtsuka T, Asamura H, Tsuchihara K, Hayashi Y, Hegab AE, Kobayashi SS, Kohno T, Watanabe H, Ornitz DM, Betsuyaku T, Soejima K, Fukunaga K. Ishioka K, et al. Among authors: kawada i. Cancer Res. 2021 Jul 15;81(14):3916-3929. doi: 10.1158/0008-5472.CAN-20-4048. Epub 2021 Jun 3. Cancer Res. 2021. PMID: 34083250
73 results